
About Esperer Onco Nutrition Private Limited
Data last updated:
Esperer Onco Nutrition Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 14 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2019PTC322571. Its GSTIN is 27AAFCE4127N1ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.37 Cr and a paid-up capital of ₹3.03 Cr. It is led by directors including Sudipta Chattopadhyay and Sohilkumar Dahyabhai Tandel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 170 Plot No 19 Sector 19D Satra Plaza Vashi, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.32 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.04 Cr (net margin 38.4%) and EBITDA of ₹2.23 Cr (EBITDA margin 41.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 81% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Esperer Nutrition. As per MCA filings, the company has open charges of ₹10.64 Lakh and satisfied charges of ₹1 Cr on record. The company has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.02 Cr; the latest was in November 2020. The company has 3 MSME Form 1 returns on record between 2021 and 2023, listing 48 overdue payments to 22 micro and small suppliers.
Esperer Onco Nutrition Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0042201). For more details, the company can be reached via its website enorma-esperernutrition.com.
Company details
Recognitions & Rankings of Esperer Onco Nutrition
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0042201
Contact details
Esperer Onco Nutrition Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is enorma-esperernutrition.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No 170 Plot No 19 Sector 19D Satra Plaza Vashi, Navi Mumbai, Maharashtra, India – 400705
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Esperer Onco Nutrition Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Esperer Onco Nutrition operates one associated brand: Esperer Nutrition. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nutrition therapies for multiple cancer diseases are developed. | esperernutrition.com |
Business activity
The main business activity of Esperer Onco Nutrition is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Esperer Onco Nutrition Private Limited, buy the company report.
Financials of Esperer Onco Nutrition Private Limited
FY 2025 filings availableEsperer Onco Nutrition Private Limited reported revenue of ₹5.32 Cr (up 754% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 81% over five years, including 754% growth in the latest year. EBITDA rose 128% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.9% | ||||
| Net Profit Margin | 38.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esperer Onco Nutrition Private Limited, buy the company report.
Board of directors of Esperer Onco Nutrition Private Limited
Esperer Onco Nutrition has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudipta Chattopadhyay Also directs: Esperer Bio-Research Private Limited, Health Voitho Technologies Private Limited, Solivara Enterprises Private Limited and 1 more | Director | 20 Dec 2023 | 2 Years 10 Months | Current |
| Sohilkumar Dahyabhai Tandel Also directs: Esperer Bio-Research Private Limited | Director | 08 Aug 2024 | 2 Years 3 Months | Current |
| Raktim Chattopadhyay | Director | 14 Mar 2019 | 7 Years 8 Months | Current |
| Riddhesh Neema Also directs: Shiv Neema Ventures LLP, Learner Aid Private Limited | Director | 20 Dec 2024 | 1 Years 10 Months | Current |
Auditor
Esperer Onco Nutrition Private Limited is audited by Bhuta Shah & Co LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bhuta Shah & Co LLP | FY 2022 | 127487 |
Shareholding
The shareholding of Esperer Onco Nutrition Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Esperer Onco Nutrition Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2025 | 101127909 | Hdfc Bank Limited | ₹10.64 Lakh | Open | |
| 14 Jul 2021 | 100459523 | Others | ₹1 Cr | Satisfied |
To see the full charge records of Esperer Onco Nutrition Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Esperer Onco Nutrition Private Limited has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.02 Cr; the latest was in November 2020.
Deals on record (2 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Esperer Bio-Research Private Limited |
To see the full deal history of Esperer Onco Nutrition Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Esperer Onco Nutrition Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Esperer Onco Nutrition Private Limited has 3 MSME Form 1 returns on record between 2021 and 2023, listing 48 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Radical Concepts and Events LLP | |||
| Scalex Business Private Limited | |||
| SK Express Services Private Limited | |||
| Avishkar Studio | |||
| TPW Logistics India Private Limited |
To see the full MSME payment records of Esperer Onco Nutrition Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Esperer Onco Nutrition Private Limited has a workforce of 12 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 12 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Esperer Onco Nutrition Private Limited, buy the company report.
GST
Esperer Onco Nutrition has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCE4127N1ZE | Maharashtra | Active | 26 Apr 2019 |
To see the full GST registrations and return filing status of Esperer Onco Nutrition Private Limited, buy the company report.
Recent activity
Esperer Onco Nutrition Private Limited has 9 board changes on record since 2019: 4 appointments and 5 cessations. The latest: Riddhesh Neema ceased to be Additional Director on 29 Sep 2025.
3 earlier events are in the company report.
News
Frequently asked questions
Esperer Onco Nutrition is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 14 March 2019 (7+ years old) and is registered under CIN U24299MH2019PTC322571.
Esperer Onco Nutrition has 4 current directors:
- Sudipta Chattopadhyay - Director
- Sohilkumar Dahyabhai Tandel - Director
- Raktim Chattopadhyay - Director
- Riddhesh Neema - Director
The latest financial statements of Esperer Onco Nutrition on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Esperer Onco Nutrition is 27AAFCE4127N1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Esperer Onco Nutrition is U24299MH2019PTC322571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esperer Onco Nutrition was incorporated on 14 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Esperer Onco Nutrition has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹15.02 Cr; the latest was in November 2020.
Riddhesh Neema ceased to be Additional Director on 29 Sep 2025. Riddhesh Neema was appointed as Director on 20 Dec 2024. Sudipta Chattopadhyay ceased to be Additional Director on 29 Sep 2024. Esperer Onco Nutrition has 9 board changes on record in total.
Yes, Esperer Onco Nutrition is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Esperer Onco Nutrition is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0042201).
Esperer Onco Nutrition has 3 MSME Form 1 returns on record between 2021 and 2023, listing 48 overdue payments to 22 micro and small suppliers. The latest return was filed on 29 Aug 2023.

